Propanc Biopharma, Inc. (PPCB) Balance Sheet
PPCB balance sheet, FY2026
June 30, 2026 · U.S. dollars$12.8M assets = $3.4M liabilities + $9.4M equity
Both columns are drawn to the same scale: what PPCB owns equals what it owes plus shareholders’ equity. Hover a block for its value.
PPCB financial health
Current ratio2.55
Comfortable · current assets cover current liabilities 2.55×
Debt / equity0.01
Low leverage · $0.01 of debt for each $1 of equity
Equity / assets73.6%
Equity-funded · of assets funded by shareholders
Cash / debt1,722.3%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal FY2026.
PPCB balance sheet trends, FY2017–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $95,069FY2017 | $12.8MFY2026 | +72.4%/yr | |
| Total liabilities | $5.5MFY2017 | $3.4MFY2026 | −5.3%/yr | |
| Shareholders’ equity | −$5.4MFY2017 | $9.4MFY2026 | — | |
| Cash & short-term investments | $69,043FY2017 | $832,006FY2026 | +31.9%/yr | |
| Total debt | $3.4MFY2017 | $48,307FY2026 | −37.7%/yr | |
| Net cash (debt) | −$3.3MFY2017 | $783,699FY2026 | +$4.1M | |
| Working capital | −$5.5MFY2017 | $5.2MFY2026 | +$10.6M | |
| Current ratio | 0.01FY2017 | 2.55FY2026 | +2.53 | |
| Debt / equity | 0.12FY2025 | 0.01FY2026 | −0.12 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
PPCB assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
PPCB liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
PPCB debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
PPCB balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $832,006 | $12,088 | $21,085 | $10,047 | $4,067 | $2,255 | $67,007 | $2,394 | $19,921 | $69,043 |
| Cash & equivalents | $832,006 | $12,088 | $21,085 | $10,047 | $4,067 | $2,255 | $67,007 | $2,394 | $19,921 | $69,043 |
| Receivables | $13,694 | $5,302 | $2,950 | $2,867 | $2,342 | $4,341 | $2,015 | $5,439 | $6,257 | $8,111 |
| Inventory | $0 | $0 | $0 | −$2,867 | $0 | −$4,341 | −$2 | −$5,439 | $0 | $0 |
| Other current assets | $7.7M | $8.3M | $1,406 | $8,992 | $8,621 | $4,341 | $2 | $88,738 | $34,712 | $4,822 |
| Total current assets | $8.5M | $8.4M | $25,441 | $19,039 | $15,030 | $6,596 | $69,022 | $91,132 | $60,890 | $81,976 |
| Property, plant & equipment (net) | $44,705 | $59,413 | $17,799 | $39,290 | $64,546 | $4,255 | $27,429 | $8,417 | $8,277 | $10,790 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $4.2M | $11.2M | $29,125 | $1,999 | $2,075 | $2,250 | $2,067 | $2,103 | $2,220 | $2,303 |
| Total assets | $12.8M | $19.6M | $72,365 | $60,328 | $81,651 | $13,101 | $98,518 | $101,652 | $71,387 | $95,069 |
| Liabilities | ||||||||||
| Accounts payable | $1.1M | $1.2M | $1.2M | $966,718 | $943,023 | $1.0M | $842,156 | $917,337 | $1.2M | $483,513 |
| Short-term debt | $24,489 | $1.6M | $889,629 | $526,638 | $998,214 | $680,083 | $1.5M | $1.6M | $4.6M | $3.4M |
| Deferred revenue | — | — | $886,802 | $1.2M | — | $1.3M | $1.1M | $1.1M | $540,354 | $689,987 |
| Total current liabilities | $3.4M | $5.6M | $3.8M | $3.2M | $3.1M | $3.1M | $3.7M | $4.4M | $6.8M | $5.5M |
| Long-term debt | $0 | $105,627 | $58,642 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | $59,413 | $19,362 | $40,783 | $62,924 | $0 | $25,072 | — | — | — |
| Other long-term liabilities | $23,818 | $41,749 | $0 | $19,278 | $42,319 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $3.4M | $5.7M | $3.9M | $3.2M | $3.1M | $3.1M | $3.7M | $4.4M | $6.8M | $5.5M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $3,797 | $11,620 | $478,802 | $7,652 | $240 | $14,056 | $258,120 | $968 | $46,429 | $4,578 |
| Retained earnings (deficit) | −$144.5M | −$125.6M | −$66.7M | −$64.7M | −$61.6M | −$58.2M | −$55.8M | −$51.0M | −$45.3M | −$38.2M |
| Treasury stock | — | — | — | — | — | — | — | — | −$46,000 | −$46,000 |
| Accumulated other comprehensive income | $1.2M | $1.3M | $1.3M | $1.3M | $1.2M | $1.1M | $1.3M | $1.1M | $357,929 | −$141,749 |
| Total shareholders' equity | $9.4M | $13.9M | −$3.8M | −$3.1M | −$3.0M | −$3.1M | −$3.6M | −$4.3M | −$6.8M | −$5.4M |
| Key figures | ||||||||||
| Total debt | $48,307 | $1.7M | $948,271 | $545,916 | $1.0M | $680,083 | $1.5M | $1.6M | $4.6M | $3.4M |
| Net cash (debt) | $783,699 | −$1.7M | −$927,186 | −$535,869 | −$1.0M | −$677,828 | −$1.4M | −$1.6M | −$4.5M | −$3.3M |
| Working capital | $5.2M | $2.8M | −$3.8M | −$3.1M | −$3.0M | −$3.1M | −$3.7M | −$4.3M | −$6.8M | −$5.5M |
| Tangible book value | $9.4M | $13.9M | −$3.8M | −$3.1M | −$3.0M | −$3.1M | −$3.6M | −$4.3M | −$6.8M | −$5.4M |
| Book value per share | — | $3.50 | — | — | — | — | — | — | — | — |
| Shares outstanding | — | 4.0M | — | — | — | — | — | — | — | — |
| Current ratio | 2.55 | 1.50 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 |
| Quick ratio | 0.25 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 |
| Debt / equity | 0.01 | 0.12 | — | — | — | — | — | — | — | — |
| Equity / assets | 73.6% | 70.8% | −5,222.2% | −5,167.1% | −3,703.1% | −23,414.8% | −3,696.2% | −4,231.3% | −9,458.2% | −5,724.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $832,006 | $443,702 | $561,237 | $602,737 | $12,088 | $50,760 | $14,633 | $9,268 | $21,085 | $6,222 | $71,650 | $6,625 |
| Cash & equivalents | $832,006 | $443,702 | $561,237 | $602,737 | $12,088 | $50,760 | $14,633 | $9,268 | $21,085 | $6,222 | $71,650 | $6,625 |
| Receivables | $13,694 | $11,056 | $16,994 | $8,383 | $5,302 | $3,633 | $1,973 | $3,309 | $2,950 | $5,265 | $127,035 | $2,634 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $7.7M | $7.8M | $7.1M | $8.2M | $8.3M | $9.7M | $1,378 | $8,957 | $1,406 | $1,368 | $12,139 | $136,545 |
| Total current assets | $8.5M | $8.2M | $7.7M | $8.8M | $8.4M | $9.7M | $17,984 | $21,534 | $25,441 | $12,855 | $210,824 | $145,804 |
| Property, plant & equipment (net) | $44,704 | $50,804 | $55,298 | $58,643 | $59,413 | $1,661 | $6,577 | $12,912 | $17,799 | $22,527 | $29,039 | $32,639 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $4.2M | $6.1M | $7.3M | $9.2M | $11.2M | $12.8M | $53,972 | $29,198 | $29,125 | $1,955 | $2,044 | $1,928 |
| Total assets | $12.8M | $14.3M | $15.1M | $18.0M | $19.6M | $22.5M | $78,533 | $63,644 | $72,365 | $37,337 | $241,907 | $180,371 |
| Liabilities | ||||||||||||
| Accounts payable | $1.1M | $973,692 | $957,483 | $1.1M | $1.2M | $1.1M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Short-term debt | $485,298 | $543,606 | $613,967 | $127,468 | $1.6M | $1.2M | $1.1M | $1.0M | $889,629 | $883,388 | $974,655 | $478,700 |
| Deferred revenue | — | — | — | — | — | — | — | $986,851 | $886,802 | — | $1.4M | $1.3M |
| Total current liabilities | $3.4M | $3.5M | $3.6M | $3.6M | $5.6M | $4.3M | $4.2M | $4.1M | $3.8M | $3.7M | $3.8M | $3.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $105,627 | $93,913 | $82,328 | $70,485 | $58,642 | $46,928 | $35,214 | $23,371 |
| Lease obligations | — | $53,591 | $56,853 | $62,580 | $59,413 | $1,862 | $7,298 | $14,185 | $19,362 | $24,265 | $30,921 | $34,307 |
| Other long-term liabilities | $23,817 | $1.0M | $35,249 | $42,080 | $41,749 | $0 | $0 | $0 | $0 | $1,942 | $8,041 | $13,146 |
| Total liabilities | $3.4M | $4.5M | $3.7M | $3.6M | $5.7M | $4.4M | $4.2M | $4.2M | $3.9M | $3.7M | $3.8M | $3.2M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $3,310 | $21,860 | $13,458 | $13,326 | $11,620 | $11,612 | $14 | $688,022 | $478,802 | $109,706 | $36,169 | $14,833 |
| Retained earnings (deficit) | −$144.5M | −$140.8M | −$134.5M | −$130.5M | −$125.6M | −$121.6M | −$67.5M | −$67.1M | −$66.7M | −$66.3M | −$65.8M | −$65.2M |
| Accumulated other comprehensive income | $1.2M | $1.3M | $1.3M | $1.3M | $1.3M | $1.5M | $1.5M | $1.2M | $1.3M | $1.3M | $1.2M | $1.4M |
| Total shareholders' equity | $9.4M | $9.8M | $11.5M | $14.4M | $13.9M | $18.1M | −$4.2M | −$4.1M | −$3.8M | −$3.7M | −$3.6M | −$3.0M |
| Key figures | ||||||||||||
| Total debt | $509,116 | $1.6M | $649,216 | $169,548 | $1.7M | $1.2M | $1.2M | $1.1M | $948,271 | $932,258 | $1.0M | $515,217 |
| Net cash (debt) | $322,890 | −$1.1M | −$87,979 | $433,189 | −$1.7M | −$1.2M | −$1.2M | −$1.1M | −$927,186 | −$926,036 | −$946,260 | −$508,592 |
| Working capital | $5.2M | $4.7M | $4.1M | $5.2M | $2.8M | $5.4M | −$4.1M | −$4.1M | −$3.8M | −$3.7M | −$3.6M | −$3.0M |
| Tangible book value | $9.4M | $9.8M | $11.5M | $14.4M | $13.9M | $18.1M | −$4.2M | −$4.1M | −$3.8M | −$3.7M | −$3.6M | −$3.0M |
| Book value per share | $2.84 | — | — | $1.16 | $1.20 | $4.18 | — | — | — | — | −$0.15 | −$0.27 |
| Shares outstanding | 3.3M | — | — | 12.3M | 11.6M | 4.3M | — | — | — | — | 23.7M | 11.0M |
| Current ratio | 2.55 | 2.37 | 2.13 | 2.45 | 1.50 | 2.24 | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 | 0.05 |
| Quick ratio | 0.25 | 0.13 | 0.16 | 0.17 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.05 | 0.00 |
| Debt / equity | 0.05 | 0.16 | 0.06 | 0.01 | 0.12 | 0.07 | — | — | — | — | — | — |
| Equity / assets | 73.6% | 68.6% | 75.8% | 79.9% | 70.8% | 80.3% | −5,295.6% | −6,454.8% | −5,222.2% | −9,908.4% | −1,473.1% | −1,657.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed September 25, 2026); data from EODHD.
PPCB financial position
At the end of fiscal 2026 (June 30, 2026), Propanc Biopharma had total assets of $12.8 million (down 34.9% from a year earlier), total liabilities of $3.4 million and shareholders' equity of $9.4 million. It held $0.8 million in cash and short-term investments against $0.0 million of debt, a net cash position of $0.8 million. Its current ratio was 2.55.
Related: PPCB income statement, PPCB cash flow statement, PPCB key metrics. See the PPCB stock overview for the latest quote and news.
PPCB balance sheet FAQ
What are Propanc Biopharma's total assets?
Propanc Biopharma reported total assets of $12.8 million at the end of fiscal 2026 (June 30, 2026), compared with $19.6 million a year earlier.
How much debt does Propanc Biopharma have?
Propanc Biopharma had $0.0 million of total debt at the end of fiscal 2026, including short-term borrowings. Its debt-to-equity ratio was 0.01.
How much cash does Propanc Biopharma have?
Propanc Biopharma held $0.8 million in cash and short-term investments at the end of fiscal 2026; with $0.0 million of debt that is net cash of $0.8 million.
What is Propanc Biopharma's book value?
Propanc Biopharma's shareholders' equity (book value) was $9.4 million at the end of fiscal 2026.
What is Propanc Biopharma's current ratio?
Propanc Biopharma had current assets of $8.5 million and current liabilities of $3.4 million, a current ratio of 2.55 (it can cover its short-term obligations).